Filter posts

Fireside Chat: James Noble Says Go for IPO

“Go for it,” was the parting advice James Noble, CEO and co-founder of Adaptimmune, had …

Biotech CEOs Speak Out on JOBS Act Success

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to …

#BIOCEO14: An Optimistic Outlook for 2014

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining …

What’s Behind the Biotech IPO Boom?

Everyone knows that it’s been a knock-out year for the biotech sector in the public …